title: Tolerability and activity of trastuzumab in elderly patients with HER2-overexpressing metastatic breast cancer.
authors.forename: G
authors.initials: G
authors.lastname: Zucchini
authors.forename: A
authors.initials: A
authors.lastname: Bernardi
authors.forename: A
authors.initials: A
authors.lastname: Martoni
authors.forename: C
authors.initials: C
authors.lastname: Zamagni
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*; D000068878:Trastuzumab
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab; C508053:ERBB2 protein, human